
### [NCIT:C7379](http://purl.obolibrary.org/obo/NCIT_C7379)
**Label:** Malignant Anal Neoplasm

**Subclasses:** [NCIT:C5602](http://purl.obolibrary.org/obo/NCIT_C5602) (Anal Kaposi Sarcoma), [NCIT:C96550](http://purl.obolibrary.org/obo/NCIT_C96550) (Anal Canal Large Cell Neuroendocrine Carcinoma), [NCIT:C96551](http://purl.obolibrary.org/obo/NCIT_C96551) (Anal Canal Small Cell Neuroendocrine Carcinoma), [NCIT:C7469](http://purl.obolibrary.org/obo/NCIT_C7469) (Anal Canal Squamous Cell Carcinoma), [NCIT:C133787](http://purl.obolibrary.org/obo/NCIT_C133787) (Anal Canal Cancer by AJCC v6 and v7 Stage), [NCIT:C96553](http://purl.obolibrary.org/obo/NCIT_C96553) (Anal Canal Mixed Adenoneuroendocrine Carcinoma), [NCIT:C5600](http://purl.obolibrary.org/obo/NCIT_C5600) (Anal Adenocarcinoma), [NCIT:C5601](http://purl.obolibrary.org/obo/NCIT_C5601) (Anal Lymphoma), [NCIT:C7489](http://purl.obolibrary.org/obo/NCIT_C7489) (Anal Canal Carcinoma), [NCIT:C6873](http://purl.obolibrary.org/obo/NCIT_C6873) (Stage IV Anal Canal Cancer AJCC v6 and v7), [NCIT:C8256](http://purl.obolibrary.org/obo/NCIT_C8256) (Anal Basaloid Carcinoma), [NCIT:C7460](http://purl.obolibrary.org/obo/NCIT_C7460) (Metastatic Malignant Neoplasm in the Anus), [NCIT:C7470](http://purl.obolibrary.org/obo/NCIT_C7470) (Anal Verrucous Carcinoma), [NCIT:C9291](http://purl.obolibrary.org/obo/NCIT_C9291) (Anal Carcinoma), [NCIT:C133800](http://purl.obolibrary.org/obo/NCIT_C133800) (Stage III Anal Cancer AJCC v8), [NCIT:C5606](http://purl.obolibrary.org/obo/NCIT_C5606) (Anal Mucinous Adenocarcinoma), [NCIT:C4639](http://purl.obolibrary.org/obo/NCIT_C4639) (Anal Melanoma), [NCIT:C133804](http://purl.obolibrary.org/obo/NCIT_C133804) (Stage IV Anal Cancer AJCC v8), [NCIT:C5609](http://purl.obolibrary.org/obo/NCIT_C5609) (Anal Glands Adenocarcinoma), [NCIT:C133794](http://purl.obolibrary.org/obo/NCIT_C133794) (Anal Cancer by AJCC v8 Stage), [NCIT:C133795](http://purl.obolibrary.org/obo/NCIT_C133795) (Stage 0 Anal Cancer AJCC v8), [NCIT:C6925](http://purl.obolibrary.org/obo/NCIT_C6925) (Anal Margin Squamous Cell Carcinoma), [NCIT:C137857](http://purl.obolibrary.org/obo/NCIT_C137857) (Refractory Anal Carcinoma), [NCIT:C27681](http://purl.obolibrary.org/obo/NCIT_C27681) (Human Papillomavirus-Related Anal Squamous Cell Carcinoma), [NCIT:C5598](http://purl.obolibrary.org/obo/NCIT_C5598) (Paget Disease of the Anus), [NCIT:C5599](http://purl.obolibrary.org/obo/NCIT_C5599) (Anal Leiomyosarcoma), [NCIT:C5610](http://purl.obolibrary.org/obo/NCIT_C5610) (Anal Rhabdomyosarcoma), [NCIT:C7776](http://purl.obolibrary.org/obo/NCIT_C7776) (Stage III Anal Canal Cancer AJCC v6 and v7), [NCIT:C5611](http://purl.obolibrary.org/obo/NCIT_C5611) (Anal Sarcoma), [NCIT:C133796](http://purl.obolibrary.org/obo/NCIT_C133796) (Stage I Anal Cancer AJCC v8), [NCIT:C5612](http://purl.obolibrary.org/obo/NCIT_C5612) (Metastatic Anal Canal Carcinoma), [NCIT:C133797](http://purl.obolibrary.org/obo/NCIT_C133797) (Stage II Anal Cancer AJCC v8), [NCIT:C7476](http://purl.obolibrary.org/obo/NCIT_C7476) (Paget Disease of the Anal Margin), [NCIT:C7794](http://purl.obolibrary.org/obo/NCIT_C7794) (Stage 0 Anal Canal Cancer AJCC v6 and v7), [NCIT:C7775](http://purl.obolibrary.org/obo/NCIT_C7775) (Stage II Anal Canal Cancer AJCC v6 and v7), [NCIT:C9037](http://purl.obolibrary.org/obo/NCIT_C9037) (Stage I Anal Canal Cancer AJCC v6 and v7), [NCIT:C7477](http://purl.obolibrary.org/obo/NCIT_C7477) (Paget Disease of the Anal Canal), [NCIT:C7472](http://purl.obolibrary.org/obo/NCIT_C7472) (Anal Margin Carcinoma), [NCIT:C7471](http://purl.obolibrary.org/obo/NCIT_C7471) (Anal Canal Adenocarcinoma), [NCIT:C7793](http://purl.obolibrary.org/obo/NCIT_C7793) (Recurrent Anal Canal Carcinoma), [NCIT:C7474](http://purl.obolibrary.org/obo/NCIT_C7474) (Anal Extramucosal (Perianal) Adenocarcinoma), [NCIT:C7473](http://purl.obolibrary.org/obo/NCIT_C7473) (Anal Margin Basal Cell Carcinoma), [NCIT:C9161](http://purl.obolibrary.org/obo/NCIT_C9161) (Anal Squamous Cell Carcinoma), [NCIT:C96549](http://purl.obolibrary.org/obo/NCIT_C96549) (Anal Canal Neuroendocrine Carcinoma), [NCIT:C96529](http://purl.obolibrary.org/obo/NCIT_C96529) (Anal Canal Undifferentiated Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C36122](http://purl.obolibrary.org/obo/NCIT_C36122) (Benign Cellular Infiltrate) 75.00%
- Thing 51.13%
- [NCIT:C42077](http://purl.obolibrary.org/obo/NCIT_C42077) (Cellular Infiltrate) 36.79%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 28.24%
- [NCIT:C35867](http://purl.obolibrary.org/obo/NCIT_C35867) (Morphologic Finding) 27.58%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 27.48%
- [NCIT:C83490](http://purl.obolibrary.org/obo/NCIT_C83490) (Microscopic Finding) 27.48%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 27.37%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 26.79%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 26.52%
- CP:0000037 0.00%
- CP:0000035 0.00%
- CP:0000028 0.00%
- CP:0000027 0.00%
- CP:0000000 0.00%


